Momentus Inc. (MNTS): Nasdaq/NYSE listing notice — Momentus receives Nasdaq deficiency notice for failing to hold annual meeting

Momentus Inc.

Received Nasdaq deficiency letter on Jan 3, 2024 for failure to hold annual meeting within 12 months of FYE Dec 31, 2022.
Must submit compliance plan by Feb 20, 2024; if accepted, Nasdaq may grant up to 180-day extension.
If plan rejected or not cured, company faces delisting from Nasdaq and expects OTC trading.
Listing remains fully effective during cure period; no immediate impact on stock trading.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Momentus Inc. received a nasdaq deficiency notice notice regarding other (rules 5620(a)).

Exchange: nasdaq
Notice: deficiency notice
Rules: 5620(a)

Exact text from the filing

January 3, 2024, Momentus Inc. (the “Company”) received a deficiency letter (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company failed to hold an annual meeting of stockholders within 12 months after its fiscal year ended December 31, 2022, as required by Nasdaq Listing Rule 5620(a) (the “Annual Meeting Requirement”). The Notice has no immediate impact on the listing of the Company’s common stock on Nasdaq, and the Company’s listing remains fully effective. Under Nasdaq Rules, the Company has 45 calendar days, or until February 20, 2024, to submit a plan to reg

View on SEC.gov

Browse all listing & compliance notices →

Momentus Inc. filing history →

Source: SEC EDGAR

accession 0001140361-24-001544

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.